CV8 THE COST-EFFECTIVENESS (COST-UTILITY) OF EPROSARTAN IN HYPERTENSIVE PATIENTS WITH CEREBROVASCULAR DISEASE IN BELGIUM, GERMANY, SPAIN, UNITED KINGDOM, AND SWEDEN
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64903-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64903-0/fulltext
Title :
CV8 THE COST-EFFECTIVENESS (COST-UTILITY) OF EPROSARTAN IN HYPERTENSIVE PATIENTS WITH CEREBROVASCULAR DISEASE IN BELGIUM, GERMANY, SPAIN, UNITED KINGDOM, AND SWEDEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64903-0&doi=10.1016/S1098-3015(10)64903-0
First page :
Section Title :
Open access? :
No
Section Order :
60